AI-Enabled Drug Discovery Cooperation
-
Drug Development
AstraZeneca and BenevolentAI Completes Third Milestone in Their AI-Enabled Drug Discovery Cooperation
AstraZeneca has identified an additional novel target for its drug development portfolio for idiopathic pulmonary fibrosis (IPF), allowing BenevolentAI, a…
Read More »